Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets close in 4 hours 6 minutes
NZX 50
11,720.97
+44.98
(+0.39%)
NZD/USD
0.6102
+0.0005
(+0.09%)
NZD/EUR
0.5616
+0.0004
(+0.07%)
ALL ORDS
8,143.50
+23.30
(+0.29%)
ASX 200
7,871.90
+20.20
(+0.26%)
OIL
79.06
-0.20
(-0.25%)
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
22.25
-0.35
(-1.55%)
At close: 03:00PM CST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
25,336,465
24,531,390
21,248,087
16,759,335
14,582,865
Cost of revenue
16,403,413
15,724,070
13,216,858
10,365,748
8,973,435
Gross profit
8,933,052
8,807,320
8,031,229
6,393,587
5,609,430
Operating expenses
Research development
79,104
80,928
74,378
44,607
4,701
Selling general and administrative
6,205,349
5,950,976
5,468,971
4,550,213
3,677,395
Total operating expenses
7,142,487
6,892,804
6,366,341
5,198,707
4,162,620
Operating income or loss
1,790,565
1,914,516
1,664,888
1,194,880
1,446,810
Interest expense
68,216
66,219
48,235
179,759
11,497
Income before tax
1,520,425
1,627,785
1,414,895
1,043,913
1,446,410
Income tax expense
360,339
397,124
335,621
239,518
363,391
Income from continuing operations
1,160,086
1,230,661
1,079,273
804,395
1,083,019
Net income
1,068,195
1,166,498
1,035,724
791,231
1,062,181
Net income available to common shareholders
1,068,195
1,166,498
1,035,724
791,231
1,062,181
Basic EPS
1.13
1.03
0.91
0.70
0.94
Diluted EPS
1.13
1.03
0.91
0.70
0.94
Basic average shares
1,140,513
1,132,523
1,138,158
1,130,330
1,132,993
Diluted average shares
1,140,513
1,132,523
1,138,158
1,130,330
1,132,993
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.